They also found lower levels of inflammatory markers (C-reactive protein, interleukin 6 and neutrophil count) among statin users compared to non-users in their study, supporting a suggested anti-inflammatory mechanism for the decreased risk of poor COVID-19 outcomes among statin users [8]. The gene discussed is CRP; the disease is COVID-19.